Impact of whey proteins on the genotoxic effects of aflatoxins in rats

International Journal of Dairy Science

Volumn 2, Issue 2, 2007, Pages 126-137

  Abd El Aziem, H Sekena ^a   Saleh, A Zeinab ^a   Farrag, A F ^a  

^a NATIONAL RESEARCH CENTRE   (Egypt)

Author keywords

Aflatoxin; Chromosomal abnormalities; DNA; Micronuclei; Whey proteins

Indexed keywords

MAMMALIA; RATTUS;

EID: 37649020576     PISSN: 18119743     EISSN: 18119751     Source Type: Journal    
DOI: 10.3923/ijds.2007.126.137     Document Type: Article

References (70)

1. Amstad, P., A. Levy, L. Emerit and P. Cerutti, 1984. Evidence for membrane-mediated chromosomal damage by AFB1 in human lymphocytes. Carcinogenesis, 5: 719-723.
2. Anderson, M.E., 1998. Glutathione: An overview of biosynthesis and modulation. Chem. Biol. Interac., 111-112: 1-14.
3. Anwar, W.A., M.M. Khalil and C.P. Wild, 1994. Micronuclei, chromosomal aberrations and aflatoxin-albumin adducts in experimental animals after exposure to aflatoxin B1. Mutat. Res., 322: 61-7.
4. AOAC "Association of Official Analytical Chemists", 1990. Official Methods of Analysis, 15th Edn. Association of Official Analytical Chemists INC, Suite 400, 2200 Wilson Boulevard, Arlington, Virginia, 22201. U.S.A.
5. Barrnett, A.J.G. and A. Tawab, 1957. A rapid method for the determination of lactose in milk and cheese. J. Sci., Food Agric., 28: 437-441.
6. Bárta, I., M. Adámková, T. Petr and J. Bártová, 1990. Dose and time dependence of chromosomal aberration yields of bone marrow cells in male Chinese hamsters after a single i.p injection of aflatoxin B1. Mutat. Res., 244: 189-195.
7. Bartfay, W.J., M.T. Davis, J.M. Medvesan and S. Lugowsk, 2003. Milk whey protein decreases oxygen free radical production in a murine model of chronic iron-overload cardiomyopathy J. Food Prot., 2: 85-94.
8. Baruchel, S. and G. Viau, 1996. In vitro selective modulation of cellular glutathione by a humanized native milk protein isolate in normal cells and rat mammary carcinoma model. Anticancer Res., 16: 1095-1100.
9. Bieri, J.C., G.S. Stoewsand, G.M. Briggs, R.W. Phillips, J.C. Woodward and J.J. Knapka, 1977. Report of the American Institute of Nutrition Ad. Hoc. Committee on Standards for Nutritional Studies. J. Nutr., 107: 1340.
10. Bodana, A.R. and D.R. Rao, 1990. Antimutagenic activity of milk fermented by Streptococcus thermophilus and Lactobacillus milk: A study on mutagenicity. J. Food Sci., 55: 1000.
11. Bose, S. and S.P. Sinha, 1991. Aflatoxin-induced structural Chromosomal changes and mitotic disruption in mouse bone marrow. Mutat. Res., 261: 15-19.
12. Bosselaers, I.E., P.W. Caessens, M.A. Van Boekel and G.M. Alink, 1994. Differential effects of milk proteins, BSA and soy protein on 4NQO-or MNNG-induced SCEs in V79 cells. Food Chem. Toxicol., 32: 905-909.
13. Bounous, G., F. Gervais, V. Amer, G. Batist and P. Gold, 1989. The influence of dietary whey protein on tissue glutathione and disease of aging. Clin. Invest. Med., 12: 343-349.
14. Bounous, G., G. Batist and P. Gold, 1991. Whey protein In cancer prevention. Cancer Lett., 1: 57: 91-94.
15. Bounous, G., 2000. Whey Protein Conventrate (WPC) and glutathione modulation in cancer treatment. Anticancer Res., 20: 4785-4792.
16. Cassand, P., H. Abdelali, C. Bouley, G. Denariaz and J.F. Narbone, 1994. Inhibitory effect of dairy products on the mutagenicities of chemicals and dietary mutagens. J. Dairy Res., 6: 46-57
17. 1 by Aspergillus flavus in a semisynthetic medium. Applied Microbiol., 14: 378.
18. Devaux, C., R. Varin, P. Mulder, V. Richard and C. Thuillez, 2001. Oxidative stress and endothelial dysfunction in heart failure. Therapie, 56: 575-581.
19. Esteve, J.M., J. Mompo, J. Garcia de la Asuncion, J. Sastre, M. Asensi, J. Boix, J.R. Vina, J. Vina and F.V. Pallardo, 1999. Oxidative damage to mitochondrial DNA and glutathione oxidation in apoptosis: Studies in vivo and in vitro. FASEB J., 13: 1055-1064.
20. Fernandes, C.F. and K.M. Shahani, 1990. Anticarcinogenic and immunological properties of dietary lactobacilli. J. Food Prot., 53: 704.
21. Gilliland, S.E., 1990. Health and nutritional benefits from lactic acid bacteria. FEMS Microbiol. Rev., 87: 175.
22. Goldin, B.R., 1989. The Role of Diet in the Causation and Prevention of Cancer. pp: 225/In: Yogurt: Nutritional and Health Properties. Chandan, R.C. (Ed.), Natl. Yogurt Assoc., McLean, VA., 6: 383.
23. Griffith, O.W., 1999. Biologic and pharmacologic regulation of mammalian glutathione synthesis. Free Radic. Biol. Med., 27: 922-935.
24. Hakkak, R., S. Korourian and S.R. Shelnutt, 2000. Diets containing whey proteins or soy protein isolate protect against 7,12-dimethylbenz(a)anthracene- induced mammary tumors in female rats. Cancer Epidemiol. Biomark. Prev., 9: 113-117.
25. Harper, W.J., 2000. Biological Properties of Whey Components. A Review. Chicago, IL: The American Dairy Products Institute and Plasma Concentrations of Some Amino Acids. Carcinogenesis, 5: 749-757.
26. Hosoda, M.H., H. Hashimito, M. Morita and A. Chiba and Hosono, 1992. Antimutagenicity of milk cultured with lactic acid bacteria against N-methyl-N′-nitro-N-nitrosoguanidine. J. Dairy Sci., 75: 976.
27. Hosono, A.K.N., A. Shashikanth and H. Otani, 1988. Antimutagenic activity of whole casein on pepper-induced mutagenicity to streptomycin-dependent strain SD 510 of Salmonella typhimurium TA 98. J. Dairy Res., 55: 334: 342.
28. Hsieh, D.P. and D.N. Atkinson, 1991. Bisfuranoid mycotoxins: Their genotoxicity and carcinogenicity. Adv. Exp. Med. Biol., 283: 525-532.
29. IDF., 1991. Significance of the indigenous antimicrobial agents of milk to the dairy industry. Bulletin of the IDF., 264: 2-19.
30. Ito, T., 1991. Science of breast milk. Food Ind., 33: 73-80.
31. Jongen, W.F., M .S. Van Boekel and L.W. Van Broekhoven, 1987. Inhibitory effect of cheese and some food constituents on mutagenicity generated in Vicia faba after treatment with nitrite. Food Chem. Toxicol., 25: 141.
32. Kennedy, R.S., G.P. Konok, G. Bounous, S. Baruchel and T.D. Lee, 1995a. The use of a whey protein concentrate in the treatment of patients with metastatic carcinoma: A phase I-II clinical study. Anticancer Res., 15: 2643-2659.
33. Kennedy, R.S., G.P. Konok and G. Bounous, 1995b. The use of a whey protein concentrate in the treatment of patients with metastatic carcinoma: A phase I-II clinical study. Anti-cancer Res., 15: 2643-2649.
34. Kent, K.D., W.J. Harper and J.A. Bomser, 2003. Effect of whey protein isolate on intracellular glutathione and oxidant-induced cell death in human prostate epiothelial cells. Toxicol. in vitro, 17: 27-33.
35. Krishnamurthy, P.B. and G.S. Neelaram, 1986. Effect of dietary fat on aflatoxin B1-induced chromosomal aberrations in mice. Toxicol. Lett., 31: 229-234.
36. Ling, E.R., 1963. A Text Book of Dairy Chemistry. Vol. II 3rd (Ed). Chapman and Hall Ltd. London.
37. Lu, S.C., 1999. Regulation of hepatic glutathione synthesis: Current concepts and controversies. FASEB J., 13: 1169-1183.
38. Matar, C., S.S. Nadathur, A.T. Bakalinsky and J. Goulet, 1997. Antimutagenic Effects of Milk Fermented by Lactobacillus helveticus L89 and a protease-deficient derivative. J. Dairy Sci., 80: 1965-1970.
39. McIntosh, G.H., G.O. Regester, R.K. Le Leu, P.J. Royle and G.W. Smithers, 1995. Dairy proteins protect against imethylhydrazine-induced intestinal cancers in rats. J. Nutr., 125: 809-816.
40. Micke, P., K.M. Beeh, J.F. Schlaak and R. Buhl, 2001. Oral supplementation with whey proteins increases plasma glutathione levels of HIV-infected patients. Eur. J. clin. Investigat., 31: 171-178.
41. Micke, P., K.M. Beeh and R. Buhl, 2002. Effects of long-term supplementation with whey proteins on plasma glutathione levels of HIV-infected patients. Eur. J. Nutr., 41: 12-18.
42. Morr, C.V. and E.Y.W. Ha, 1993. Whey protein concentrates and isolate processing and functional properties. Crit. Rev. Food Sci. Nutr., 33: 431-476.
43. Nadathur, S.R., S.J. Gould and A.T. Bakalinsky, 1994. Antimutagenicity of fermented milk. J. Dairy Sci., 77: 3287.
44. Nadathur, S.R., S.J. Gould and A.T. Bakalinsky, 1995. Antimutagenicity of an acetone extract of yogurt. Mutat. Res., 334: 213.
45. Nelson, W.G., A.M. De Marzo and T.L. DeWeese, 2001. The molecular pathologenesis of prostate cancer: Implications for prostate cancer prevention. Urology, 57(Suppl. 4A): 39-57.
46. Nixon, J.E., J.D. Hendrick, N.E. Pawlowski, P.W. Loveland and R.O. Sinnhuber, 1981. Carcinogenicity of aflatoxin in Fisher 344 rats. J. Natl. Cancer Inst., 66: 1159-1163.
47. Park, Y. and B.L. Bullerman, 1983. Effect of substrate and temperature on aflatoxin production by Aspergillus parasiticus and Aspergillus flavus. J. Food Prot., 46: 178.
48. Parodi, P.W., 1998. A role for milk proteins in cancer prevention. Aust. J. Dairy Technol., 38: 144-148.
49. Preston, R.J., B.J. Dean, S. Galloway, H. Holden, A.F. McFee and M. Shelby, 1987. Mammalian in vivo cytogenetic assay. Mutat. Res., 189: 157-165.
50. Reeves, P.G., F.H. Nielson and G.C.JR. Fahey, 1993. Ain-93 purified diets for laboratory rodents: Final report of the American Institute of Nutrition ad hoc writing committee on the reformulation of the AIN-76 rodent diet. J. Nutr., 123: 1939-1951.
51. Russo, A., 2000. In vivo cytogenetics: Mammalian germ cells. Mutat. Res., 455: 167-189.
52. Salassidis, K., U. Kulka, E. Schmid, D. Paul and M. Bauchinger, 1991. Induction of chromosome aberrations and sister chromatid exchange by indirectly acting mutagens in immortal mouse and rat hepatocyte lines. Mutagenesis, 6: 59-63.
53. Salamone, M., J. Heddle, E. Stuart and M. Kotz, 1980. Towards as improved micronucleus test: Studies on 3 model agents. Mitomycin C. cyclophosphamide and dimethylbenzanthracene. Mutat. Res., 74: 347-356.
54. Saleh, Z.A., Abdel-kader, M. Madeha, F.A. El-Shobaki and El-Hawary and M. Zeinab, 2000, The Influence of vitamins with reducing characters on toxicity of aflatoxin contaminated diet. Med. J. Cairo Univ., 68 (Suppl.): 187-196.
55. Schneider, W.C., 1957. Determination of Nucleic Acids in Tissues by Pentose Analysis. In: Methods of Enzymology, Vol. 3, Colowick, S.P. and N.O. Kaplan, Eds., Academic Press, New York, pp: 680-684.
56. Sekine, K., E. Watanabe, J. Nakamura, N. Takasuka, D.J. Kim, M.Asamoto, V. Krutovskikh, H. Baba-Toriyama, T. Ota, M.A. Moore, M. Masuda, H. Sugimoto, H. Nishino, T. Kakizoe and H. Tsuda, 1997. Inhibition of azoxymethane-initiated colon tumor by bovine lactoferrin administration in F344 rats. Japanese J. Cancer Res., 88: 523-526.
57. Sen, C.K., 1997. Nutritional biochemistry of glutathione. Nut. Biochem., 8: 660-672.
58. 1: evidence for a recombination-mediated mechanism in Saccharomyces cerevisiae. Cancer Res., 56: 5457-5465.
59. 1 in mixed feeds. J. Assoc. Anal. Chem., 66: 582.
60. Shih, C.V. and E.H. Marth, 1971. A procedure for rapid recovery of aflatoxins from cheese and other foods. J. Milk Food Technol., 34: 119.
61. Smela, M.E., S.S. Currier, E.A. Bailey and J.M. Essigmann, 2001. The chemistry and biology of aflatoxin B 1, from mutational spectrometry to carcinogenesis. Carcinogenesis, 22: 535-545.
62. Smithers, G.W., F.J. Ballard, A.D. Copeland, K.J. De Silva, D.A. Dionysius, G.L. Francecis, C. Goddard, P.A. Grieve, G.H. McIntosh, I.R. Mitchell, R.J. Pearce and G.O. Regesterm, 1996. New opportunities from the isolation and utilization of whey proteins. J. Dairy Sci., 79: 1454-1459.
63. Taniguchi, M., A. Yasutake and K. Takedomi, 2000. Effects of dietary sulfur-containing amino acids on oxidative damage in rat liver caused by N-nitrosodimethylamine administration. Br. J. Nutr., 84: 211-217.
64. Teramoto, S., T. Tomita, H. Matsui, E. Ohga, T. Matsuse and Y. Ouchi, 1999. Hydrogen peroxide-induced apoptosis and necrosis in human lung fibroblasts: protective roles of glutathione. Japanese J. Pharmacol., 79: 33-40.
65. Tsai, W.Y., W.H. Chang and C.H. Chen, 2000. Enhancing effect of patented whey protein isolate (immunocal) on cytotoxcity of an anticancer drug. Nutr. Cancer, 38: 200-208.
66. Tsuda, H., K. Sekine, Y. Ushida, T. Kuhara, N. Takasuka, M. Iigo,B.S. Han and M.A. Moore, 2000. Milk and dairy products in cancer prevention: Focus on bovine lactoferrin. Mutat. Res., 462: 227-233.
67. Umegaki, K., H. Uramoto and T. Esashi, 1997. Lack of influence of a long-term high or low vitamin E diet on oxidative DNA damage in the bone marrow of mice. Int. J. Vitamin. Nutr. Res., 67: 149-154.
68. Van Boekel, M.S., C.M. Weerens, A. Holstra, C.E. Scheidtweiler and G.M. Alink, 1993. Antimutagenic effects of casein and its digestion products. Food Chem. Toxicol., 31: 731.
69. Van Rensburg, S.J., P. Cook-Mozaffari, D.J. Van Schalwyck, J.J. Van der Watt, T.J. Vincent and I.F. Purchase, 1985. Hepatocellular carcinoma and dietary aflatoxin in Mozambique and Transkei. Br. J. Cancer, 51: 713-722.
70. Yeh, F.S., M.C. Yu, C.C. Mo, S. Luo, M.J. Tong and B.J. Herderson, 1989. Hepatitis B virus, aflatoxins and hepatocellular carcinoma in southern Guangxi, China. Cancer Res., 39: 454-553.